WellSpring is pleased to announce the release of a new eBook: Managing Risk and Ensuring Success With a Contract Manufacturing Partner. Any long-term commercial relationship, especially between a drug innovator and its CMO, requires a number of things to remain sound: ongoing dialogue, common expectations, milestones and metrics, responsiveness, secure data access and more. With time, these relational and transactional exchanges build a collaborative bridge that pushes risk out and business success into these highly technical and complex relationships.
We are pleased to announce the appointment of Mr. David Mayers as President, WellSpring Pharma Services. David brings 25 years of Pharmaceutical Manufacturing experience; most recently as Vice President Manufacturing Operations at Purdue Pharma. David will join the senior leadership team and will assume immediate responsibility for all activities associated with the Pharma Services business unit, overseeing Plant Operations, Business Development and Quality & Regulatory Affairs.
Topics: Organizational Announcements